col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


165 Results       Page 1

 [1] 
Elsevier: Clinical Immunology
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Feb―28 Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals Eugenia Galeota, Valeria Bevilacqua, Andrea Gobbini, Paola Gruarin, Mauro Bombaci, Elisa Pesce, Andrea Favalli, Andrea Lombardi, Francesca Vincenti, Jessica Ongaro, Tanya Fabbris, Serena Curti, Martina Martinovic, Mirco Toccafondi, Mariangela Lorenzo, Angelica Critelli, Francesca Clemente, Mariacristina Crosti, Maria Lucia Sarnicola, Manuele Martinelli, Lucia La Sala, Alejandro Espadas, Lorena Donnici, Maria Orietta Borghi, Tullia De Feo, Raffaele De Francesco, Daniele Prati, Pier Luigi Meroni, Samuele Notarbartolo, Jens Geginat, Andrea Gori, Alessandra Bandera, Sergio Abrignani, Renata Grifantini
2 [GO] 2024―Jan―11 Immune correlates with disease severity in older patients after SARS-CoV-2 BA.2 infection in Hong Kong Na Liu, Runhong Zhou, Anthony Raymond Tam, Wing-Ming Chu, Dawei Yang, Haode Huang, Qiaoli Peng, Zhenglong Du, Bohao Chen, Kelvin Kai-Wang To, Zhiwei Chen
3 [GO] 2024―Jan―11 A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants Abhishek Chiyyeadu, Girmay Asgedom, Matthias Bruhn, Cheila Rocha, Tom U. Schlegel, Thomas Neumann, Melanie Galla, Philippe Vollmer Barbosa, Markus Hoffmann, Katrin Ehrhardt, Teng-Cheong Ha, Michael Morgan, Clara T. Schoeder, Stefan Pöhlmann, Ulrich Kalinke, Axel Schambach
4 [GO] 2023―Dec―27 Autoimmune and auto-inflammatory adverse events after COVID-19 vaccination in the United States Seong-Jang Kim, Taeho Greg Rhee, Sung Ryul Shim
5 [GO] 2023―Dec―19 The spectrum of side effects associated with COVID-19 vaccines in patients with inborn errors of immunity Cansu Özdemiral, Nadira Nabiyeva Cevik, Gizem Yavuz, Onuralp Gormez, Ayse Betül Zengin, Saliha Esenboga, Erdem Karabulut, Deniz Cagdas
6 [GO] 2023―Nov―22 Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk Marc Emmenegger, Vishalini Emmenegger, Srikanth Mairpady Shambat, Thomas C. Scheier, Alejandro Gomez-Mejia, Chun-Chi Chang, Pedro D. Wendel-Garcia, Philip K. Buehler, Thomas Buettner, Dirk Roggenbuck, Silvio D. Brugger, Katrin B.M. Frauenknecht
7 [GO] 2023―Nov―10 Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production Emily S. Córneo, Flavio Protasio Veras, Giovanni F. Gomes, Ayda H. Schneider, Bruna Manuella, Cicero J.L.R. Almeida, Camila M. Silva, Ronaldo B. Martins, Sabrina S. Batah, Carla S. Simon, Gabriele da S. Prestes, José Carlos Alves-Filho, Eurico Arruda, Paulo Louzada-Junior, Renê D.R. de Oliveira, Alexandre T. Fabro, Thiago M. Cunha, Fernando Queiroz Cunha, Felipe Dal-Pizzol
8 [GO] 2023―Oct―16 Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors Katherine A. Drake, Dimitri Talantov, Gary J. Tong, Jack T. Lin, Simon Verheijden, Samuel Katz, Jacqueline M. Leung, Benjamin Yuen, Vinod Krishna, Michelle J. Wu, Alex Sutherland, Sarah A. Short, Pouya Kheradpour, Maxwell Mumbach, Kate M. Franz, Vladimir Trifonov, Molly V. Lucas, James Merson, Charles C. Kim, Chen Chen, Sairam Parthasarathy, Victor F. Tapson, James N. Moy, Christopher R. de Filippi, Ivan O. Rosas, Mujeeb Basit, Mirella Salvatore, Jerry A. Krishnan
9 [GO] 2023―Oct―11 T regulatory lymphocytes specific for SARS-CoV-2 display increased functional plasticity Laura Esparcia-Pinedo, Ángel Lancho-Sánchez, Ilya Tsukalov, María I. Pacheco, Pedro Martínez-Fleta, Belén Pérez-Miés, José Palacios-Calvo, Francisco Sánchez-Madrid, Enrique Martín-Gayo, Arantzazu Alfranca
10 [GO] 2023―Sep―03 Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children Donato Amodio, Giuseppe Rubens Pascucci, Nicola Cotugno, Chiara Rossetti, Emma Concetta Manno, Chiara Pighi, Elena Morrocchi, Annamaria D'Alessandro, Marco Alfonso Perrone, Alessandra Valentini, Alessio Franceschini, Marcello Chinali, Annalisa Deodati, Chiara Azzari, Paolo Rossi, Stefano Cianfarani, Marco Andreani, Ottavia Porzio, Paolo Palma
11 [GO] 2023―Aug―14 Clinical characteristics and immune profiles of patients with immune-mediated alopecia associated with COVID-19 vaccinations Chuang-Wei Wang, Ming-Ying Wu, Chun-Bing Chen, Wei-Chen Lin, Jennifer Wu, Chun-Wei Lu, Wei-Ti Chen, Fang-Ying Wang, Rosaline Chung-Yee Hui, Min-Hui Chi, Tsu-Man Chiu, Ya-Ching Chang, Jing Yi Lin, Yang Yu-Wei Lin, Wan-Ting Tsai, Shuen-Iu Hung, Wen-Hung Chung
12 [GO] 2023―Jul―26 Cytolytic CD8+ T cell response to SARS-CoV-2 and non-SARS-CoV-2-related viruses is associated with severe manifestation of COVID-19 Kristina Allers, Verena Moos, Jörg Hofmann, Mario Witkowski, Hildrun Haibel, Stefan Angermair, Thomas Schneider
13 [GO] 2023―Jul―22 Behçet's patients' response to COVID-19 vaccination Bindi Gokani, Sarah Sacoor, Georgia R. Leisegang, William Ogunkolade, Azimoon Bibi, Sofia Grigoriadou, Corinna Pade, Joseph Gibbons, Amal Senusi, Farida Fortune
14 [GO] 2023―Jul―13 SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype Silvestri Ylenia, Clemente Francesca, Moschetti Giorgia, Maioli Sara, Carelli Elena, Espadas de Arias Alejandro, Torelli Rosanna, Longhi Elena, De Feo Tullia, Crosti Maria Cristina, Sarnicola Maria Lucia, Salvi Mario, Mantovani Giovanna, Arosio Maura, Bombaci Mauro, Pesce Elisa, Grifantini Renata, Abrignani Sergio, Geginat Jens, Muller Ilaria
15 [GO] 2023―Jul―05 NETosis promotes chronic inflammation and fibrosis in systemic lupus erythematosus and COVID-19 Huiqing Lin, Jiejie Liu, Ning Li, Birong Zhang, Van Dien Nguyen, Peipei Yao, Jiangpeng Feng, Qianyun Liu, Yu Chen, Guang Li, You Zhou, Li Zhou
16 [GO] 2023―May―30 Increase in the number of new cases of ANCA-associated vasculitis in the COVID-19 vaccine era Tomohito Sato, Masataka Umeda, Shuntaro Sato, Toru Michitsuji, Toshimasa Shimizu, Tomohiro Koga, Yuki Furuse, Atsushi Kawakami
17 [GO] 2023―May―23 Association of SARS-COV-2 viral RNAemia, IL- 6 gene polymorphism, serum IL-6 and peripheral blood lymphocytes and monocytes with disease severity in COVID-19 patients Shirin Tarafder, Nur Mohammad Khan
18 [GO] 2023―May―23 Retrospective Study on Vaccine Responses and Natural Course of COVID-19 Infections in Primary Immunodeficiency Tracy Hwangpo, Harry Schroeder
19 [GO] 2023―May―23 COVID-19-Related Encephalitis in a Child with PIK3CD Defect David Potts, Melis Yilmaz, Priya Patel, Minh Nguyen, Joseph Dasso, Boglarka Ujhazi, Sumai Gordon, Krisztian Csomos, Monica Hajirawala, Jolan Walter
20 [GO] 2023―May―23 Anti-interferon-alpha autoantibodies in patients with inborn errors of Immunity and rheumatic diseases before and during the COVID-19 pandemic Joseph Dasso, Boglarka Ujhazi, Peter Illes, Sumai Gordon, Serena Shaffren, Eugenia Alas, Krisztian Csomos, Ann Marie Szymanski, Jolan Walter
21 [GO] 2023―May―23 Characteristics and Clinical Implications of Anti-IFN-α cytokine antibodies in partial Recombinase Activating Gene Deficiency patients before and during the COVID-19 Pandemic Sumai Gordon, Melis Yilmaz, Joseph Dasso, Caterina Cancrini, Karlla Brigatti, Kevin Strauss, Krisztian Csomos, Jolan Walter, Boglarka Ujhazi, Francesco Licciardi
22 [GO] 2023―May―23 A comprehensive knowledgebase of known and predicted human genetic variants associated with COVID-19 susceptibility and severity Meltem Ece Kars, David Stein, Cigdem Sevim Bayrak, Peter Stenson, David Cooper, Yuval Itan
23 [GO] 2023―May―23 Fatal COVID-19 in an infant prompted an early diagnosis of ZNFX1 deficiency in a sibling Raed Alzyoud, Motasem Alsuweiti
24 [GO] 2023―May―23 Mild COVID-19 clinical course among paediatric patients with primary immunodeficiency Marina Sham, Myra Pereira, Linda Vong, Laura Abrego Fuentes, Abdulrahman Al Ghamdi, Ori Scott, Julia Upton, Vy Hong-Diep Kim, Chaim Roifman
25 [GO] 2023―May―23 Mild COVID-19 outcomes in adults with inborn errors of immunity: a single-center experience Laura Abrego Fuentes, Marina Sham, Myra Pereira, Linda Vong, Ori Scott, Abdulrahman Al Ghamdi, Chaim Roifman
26 [GO] 2023―May―23 A Case of a Relapsing Remitting Macrophage Activating Syndrome After Covid-19 Vaccine In a Teenager with UNC13D Heterozygous Variant of Uncertain Significance Jessica Simpson, Hanadys Ale, Kristina Wiers-Shamir
27 [GO] 2023―May―23 Surveillance of anti-SARS-CoV-2 antibodies in plasma pools and in immunoglobulin medicinal products manufactured since 2020 has shown high neutralizing activity against SARS-CoV-2 and current variants Carolina Romero, José María Diez, Rodrigo Gajardo
28 [GO] 2023―May―23 Association Between Severe SARS-CoV-2 Infection and De Novo HLA Donor Specific Antibody Production in Lung Transplant Recipients: Single-center study Sadia Shah, Zeying Du, Si Pham, Mohamed Elrefaei
29 [GO] 2023―May―23 Immunoglobulin replacement products in current clinical use in the United States have poor neutralizing activity against SARS-CoV-2 Omicron strains Alexa Doss, Chieh-Yu Liang, Jennifer Monroy, James Wedner, Christopher Rigell, Hannah Davis-Adams, Lucas Adams, Peggy Kendall, Michael Diamond, Ofer Zimmerman
30 [GO] 2023―May―23 Characterization of Adaptive Immune Responses to SARS-CoV-2 Updated Bivalent Booster Brianna Wachter, Kalpana Manthiram, Qin Xu, Lihong Shi, Pamela Schwartzberg, Peter Burbelo, Muhammad Tauseef Rehman, Robin Dewar, Luigi Notarangelo, Ottavia Delmonte
31 [GO] 2023―May―23 Patients with hereditary angioedema and patients with SARS-CoV-2-associated pneumonia - what can be similar? Irina Guryanova, Aliaksandr Liubushkin, Viktoria Kazak, Yulia Zharankova, Inessa Doronina, Alexandr Migas, Mikhail Belevtsev
32 [GO] 2023―May―05 Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients Andrew D. Hoffmann, Sam E. Weinberg, Suchitra Swaminathan, Shuvam Chaudhuri, Hannah Faisal Mubarak, Matthew J. Schipma, Chengsheng Mao, Xinkun Wang, Lamiaa El-Shennawy, Nurmaa K. Dashzeveg, Juncheng Wei, Paul J. Mehl, Laura J. Shihadah, Ching Man Wai, Carolina Ostiguin, Yuzhi Jia, Paolo D'Amico, Neale R. Wang, Yuan Luo, Alexis R. Demonbreun, Michael G. Ison, Huiping Liu, Deyu Fang
33 [GO] 2023―May―03 Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] Matthew K. Wong, Jun T. Liu, Patrick Budylowksi, Feng Yun Yue, Zhijie Li, James M. Rini, James R. Carlyle, Amin Zia, Mario Ostrowski, Alberto Martin
34 [GO] 2023―Apr―28 Triple immune modulator therapy for aberrant hyperinflammatory responses in severe COVID-19 June-Young Koh, Jae-Hoon Ko, So Yun Lim, Seongman Bae, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Chi Ryang Chung, Sung-Han Kim, Kyong Ran Peck, Jeong Seok Lee
35 [GO] 2023―Apr―24 Pre-existing humoral immunity and CD4+ T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination Ching-Fen Shen, Yi-Chen Fu, Tzong-Shiann Ho, Po-Lin Chen, Nan-Yao Lee, Bo-Yang Tsai, Pei-Jane Tsai, Wen-Chien Ko, Ching-Chuan Liu, Chao-Min Cheng, Chi-Chang Shieh
36 [GO] 2023―Feb―20 Adaptive immune dysfunction in patients with COVID-19 and impaired kidney function during the omicron surge Jiayi Yan, Jieying Wang, Li Ding, Shang Liu, Yaping Zhan, Jiayue Lu, Zhenyuan Li, Leyi Gu, Ping Li, Mingli Zhu, Yuan Gao, XingRong Gong, Haiqun Ban, Hong Cai, Shan Mou
37 [GO] 2023―Feb―16 Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity Marc Scherlinger, Jean Sibilia, George C. Tsokos, Jacques-Eric Gottenberg
38 [GO] 2023―Jan―28 Induction and subsequent decline of S1-specific T cell reactivity after COVID-19 vaccination Andreas Törnell, Hanna Grauers Wiktorin, Johan Ringlander, Mohammad Arabpour, Staffan Nilsson, Magnus Lindh, Martin Lagging, Kristoffer Hellstrand, Anna Martner
39 [GO] 2023―Jan―21 Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling Akrivi Chrysanthopoulou, Christina Antoniadou, Anastasia-Maria Natsi, Efstratios Gavriilidis, Vasileios Papadopoulos, Evangelia Xingi, Stylianos Didaskalou, Dimitrios Mikroulis, Victoria Tsironidou, Konstantinos Kambas, Maria Koffa, Panagiotis Skendros, Konstantinos Ritis
40 [GO] 2022―Dec―29 Early prediction of COVID-19 outcome using artificial intelligence techniques and only five laboratory indices Panagiotis G. Asteris, Styliani Kokoris, Eleni Gavriilaki, Markos Z. Tsoukalas, Panagiotis Houpas, Maria Paneta, Andreas Koutzas, Theodoros Argyropoulos, Nizar Faisal Alkayem, Danial J. Armaghani, Abidhan Bardhan, Liborio Cavaleri, Maosen Cao, Iman Mansouri, Ahmed Salih Mohammed, Pijush Samui, Gloria Gerber, Dimitrios T. Boumpas, Argyrios Tsantes, Evangelos Terpos, Meletios A. Dimopoulos
41 [GO] 2022―Dec―17 Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19 Weng Hua Khoo, Katherine Jackson, Chansavath Phetsouphanh, John J. Zaunders, José Alquicira-Hernandez, Seyhan Yazar, Stephanie Ruiz-Diaz, Mandeep Singh, Rama Dhenni, Wunna Kyaw, Fiona Tea, Vera Merheb, Fiona X.Z. Lee, Rebecca Burrell, Annaleise Howard-Jones, Archana Koirala, Li Zhou, Aysen Yuksel, Daniel R. Catchpoole, Catherine L. Lai, Tennille L. Vitagliano, Romain Rouet, Daniel Christ, Benjamin Tang, Nicholas P. West, Shane George, John Gerrard, Peter I. Croucher, Anthony D. Kelleher, Christopher G. Goodnow, Jonathan D. Sprent, Joseph E. Powell, Fabienne Brilot, Ralph Nanan, Peter S. Hsu, Elissa K. Deenick, Philip N. Britton, Tri Giang Phan
42 [GO] 2022―Nov―08 Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities Murad Alahdal, Eyad Elkord
43 [GO] 2022―Oct―08 Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental dose Emily Rose, Daniel Magliulo, Vasileios C. Kyttaris
44 [GO] 2022―Sep―30 Immunological characteristics of severe acute hepatitis of unknown origin in a child post SARS-CoV-2 infection Atsushi Morita, Kazuo Imagawa, Kei Asayama, Tsubasa Terakado, Shoko Takahashi, Katsuyuki Yaita, Manabu Tagawa, Daisuke Matsubara, Hidetoshi Takada
45 [GO] 2022―Aug―30 Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors Bi-Nan Lu, Ka-Li Zhu, Xiao-Ming Cui, Lin Yao, Xue-Jun Wang, Guo-Lin Wang, Li-Jun Duan, Aruna Qian, Mai-Juan Ma
46 [GO] 2022―Aug―30 SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children Ki Pui Lam, Marcos Chiñas, Amélie M. Julé, Maria Taylor, Marina Ohashi, Mehdi Benamar, Elena Crestani, Mary Beth F. Son, Janet Chou, Catherine Gebhart, Talal Chatila, Jane Newburger, Adrienne Randolph, Maria Gutierrez-Arcelus, Lauren A. Henderson
47 [GO] 2022―Aug―13 COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review Emily Drzymalla, Ridgely Fisk Green, Martha Knuth, Muin J. Khoury, W. David Dotson, Adi Gundlapalli
48 [GO] 2022―Aug―06 Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19 Yuan-Yuan Yong, Li Zhang, Yu-Jiao Hu, Jian-Ming Wu, Lu Yan, Yi-Ru Pan, Yong Tang, Lu Yu, Betty Yuen-Kwan Law, Chong-Lin Yu, Jie Zhou, Mao Li, Da-Lian Qin, Xiao-Gang Zhou, An-Guo Wu
49 [GO] 2022―Aug―06 Decrease in CD8+CD45+CCR7+CD62L+ T cells in individuals vaccinated with Sinovac-CoronaVac following COVID-19 infection Dâmaris C.S.C. Fonseca, Mirtes C.B. Rocha, Lucca A. Pereira, Leticia P. Botega, Susanne C.P.F. Cutrim, Fabiano V. Silva, Flávio D. Batista, Adriana S. Rêgo, Ângela Falcai, Lídio G. Lima-Neto, Ana Paula S.A. Santos, Rafael C. Carvalho, Eduardo M. Sousa
50 [GO] 2022―Aug―06 Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: An Italian experience Maria Infantino, Lorenza Morena, Massimo Antonio Di Pietro, Benedetta Romanin, Barbara Cimolato, Beatrice Anna Luisa Rocca, Silvia Tunnera, Giulia Modi, Marta Tilli, Valentina Grossi, Barbara Lari, Helena Cerutti, Giulia Tesi, Valentina Anrò, Alessandra Cartocci, Maurizio Benucci, Francesca Veneziani, Patrizia Casprini, Mariangela Manfredi
51 [GO] 2022―Jun―25 High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19 Mirko Scordio, Federica Frasca, Letizia Santinelli, Leonardo Sorrentino, Alessandra Pierangeli, Ombretta Turriziani, Claudio M. Mastroianni, Guido Antonelli, Raphael P. Viscidi, Gabriella d'Ettorre, Carolina Scagnolari
52 [GO] 2022―May―02 SARS-CoV-2/COVID-19 and its relationship with NOD2 and ubiquitination Edgardo Guzman Rivera, Asha Patnaik, Joann Salvemini, Sanjeev Jain, Katherine Lee, Daniel Lozeau, Qingping Yao
53 [GO] 2022―Apr―27 Myeloid-derived suppressor cells in COVID-19: A review Yuliya V. Perfilyeva, Yekaterina O. Ostapchuk, Raikhan Tleulieva, Aykin Kali, Nurshat Abdolla, Vladimir K. Krasnoshtanov, Anastassiya V. Perfilyeva, Nikolai N. Belyaev
54 [GO] 2022―Apr―26 Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update Wen Zhang, Chenman Qin, Yunyun Fei, Min Shen, Yangzhong Zhou, Yan Zhang, Xiaofeng Zeng, Shuyang Zhang
55 [GO] 2022―Apr―18 Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure Efstratios Gavriilidis, Christina Antoniadou, Akrivi Chrysanthopoulou, Maria Ntinopoulou, Andreas Smyrlis, Iliana Fotiadou, Nikoleta Zioga, Dionysios Kogias, Anastasia-Maria Natsi, Christos Pelekoudas, Evangelia Satiridou, Stefania-Aspasia Bakola, Charalampos Papagoras, Ioannis Mitroulis, Paschalis Peichamperis, Dimitrios Mikroulis, Vasileios Papadopoulos, Panagiotis Skendros, Konstantinos Ritis
56 [GO] 2022―Apr―07 Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients Masaru Takeshita, Naoshi Nishina, Saya Moriyama, Yoshimasa Takahashi, Makoto Ishii, Hideyuki Saya, Yasushi Kondo, Yuko Kaneko, Katsuya Suzuki, Koichi Fukunaga, Tsutomu Takeuchi
57 [GO] 2022―Apr―05 Protective HLA alleles against severe COVID-19: HLA-A*68 as an ancestral protection allele in Tapachula-Chiapas, Mexico Susana Hernández-Doño, Roberto Alejandro Sánchez-González, Ma Guadalupe Trujillo-Vizuet, Fabiola Yeseline Zamudio-Castellanos, Rafael García-Silva, Pedro Bulos-Rodríguez, Carlos A. Vazquez-Guzmán, Ximena Cárdenas-Ramos, Diana de León Rodríguez, Fabiola Elías, Sergio Domínguez-Arevillaga, José Manuel Pérez-Tirado, Olga Lidia Vera-Lastra, Julio Granados, Jesús Sepúlveda-Delgado
58 [GO] 2022―Mar―29 Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19 Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, Cory Perugino, Vinay S. Mahajan, Jocelyn R. Farmer, Hang Liu, Thomas J. Diefenbach, Alicja Piechocka-Trocha, Kristina Lefteri, Michael T. Waring, Katherine R. Premo, Bruce D. Walker, Jonathan Z. Li, Gaurav Gaiha, Xu G. Yu, Mathias Lichterfeld, Robert F. Padera, Shiv Pillai
59 [GO] 2022―Mar―23 Pandemic chilblains: Are they SARS-CoV-2-related or not? Axel De Greef, Pierre G. Coulie, Marie Baeck
60 [GO] 2022―Mar―17 Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants Divya Gupta, Farhan Ahmed, Dixit Tandel, Haripriya Parthasarathy, Dhiviya Vedagiri, Vishal Sah, B. Krishna Mohan, Rafiq Ahmad Khan, Chiranjeevi Kondiparthi, Prabhudas Savari, Sandesh Jain, Shashikala Reddy, Jerald Mahesh Kumar, Nooruddin Khan, Krishnan Harinivas Harshan
61 [GO] 2022―Mar―14 Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response Yves Renaudineau, Florence Abravanel, Jacques Izopet, Chloé Bost, Emmanuel Treiner, Nicolas Congy, Antoine Blancher
62 [GO] 2022―Mar―05 Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine Matthew K. Wong, Jun T. Liu, Patrick Budylowksi, Feng Yun Yue, Zhijie Li, James M. Rini, James R. Carlyle, Amin Zia, Mario Ostrowski, Alberto Martin
63 [GO] 2022―Feb―25 Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis Hristos Karakizlis, Christian Nahrgang, Kevin Strecker, Jiangping Chen, Mostafa Aly, Heiko Slanina, Christian G. Schüttler, Isla Esso, Martin Wolter, Darina Todorova, Sönke Jessen, Andrea Adamik, Claudio Ronco, Werner Seeger, Rolf Weimer, Martina Sester, Horst-Walter Birk, Faeq Husain-Syed
64 [GO] 2022―Feb―24 A global survey in the developmental landscape of possible vaccination strategies for COVID-19 Amin Gasmi, Shvetha Srinath, Maryam Dadar, Lyudmila Pivina, Alain Menzel, Asma Gasmi Benahmed, Salvatore Chirumbolo, Geir Bjørklund
65 [GO] 2022―Feb―24 Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response Paul S. Kim, Derek E. Dimcheff, Andrew Siler, Richard J. Schildhouse, Stephen W. Chensue
66 [GO] 2022―Feb―09 The FCGR2Ars1801274 polymorphism was associated with the risk of death among COVID-19 patients Rocío López-Martínez, Guillermo M. Albaiceta, Laura Amado-Rodríguez, Elías Cuesta-Llavona, Juan Gómez, Marta García-Clemente, Daniel Vázquez-Coto, Victoria Alvarez, Eliecer Coto
67 [GO] 2022―Jan―25 Protracted or recurrent COVID-19 associated cytokine storm in a patient with chronic lymphocytic leukemia receiving rituximab-based chemotherapy Murat Bektaş, Gökhan Özdemir
68 [GO] 2022―Jan―19 Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study Mahmoud M. Alseoudy, Mohamed Elgamal, Dalia A. Abdelghany, Asmaa M. Borg, Ahmed El-Mesery, Dina Elzeiny, Maha O. Hammad
69 [GO] 2021―Dec―29 Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring Antonio Cristiano, Massimo Pieri, Serena Sarubbi, Martina Pelagalli, Graziella Calugi, Flaminia Tomassetti, Sergio Bernardini, Marzia Nuccetelli
70 [GO] 2021―Dec―18 Association of KIR gene polymorphisms with COVID-19 disease Ali Hajeer, Dunia Jawdat, Salam Massadeh, Nora Aljawini, Malak S. Abedalthagafi, Yaseen M. Arabi, Manal Alaamery
71 [GO] 2021―Nov―27 Immunogenicity of SARS-CoV2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters Daniel Magliulo, Stefanie D. Wade, Vasileios C. Kyttaris
72 [GO] 2021―Nov―16 Role of NRF2 and Sirtuin activators in COVID-19 Hasnat Khan, Shivangi Patel, Anuradha Majumdar
73 [GO] 2021―Nov―09 Adult-onset Still's disease following mRNA COVID-19 vaccination Amir Sharabi, Shachaf Shiber, Yair Molad
74 [GO] 2021―Oct―05 Determination of neutralising anti-SARS-CoV-2 antibody half-life in COVID-19 convalescent donors Thomas W. Barnes, Johannes Schulte-Pelkum, Laura Steller, Daniel Filchtinski, Robin Jenness, Michelle R. Williams, Christina Kober, Sandro Manni, Thomas Hauser, Aaron Hahn, Uwe Kalina, Toby L. Simon, Patrick Schuetz, Nathan J. Roth
75 [GO] 2021―Sep―30 Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19 Jiezhong Chen, Luis Vitetta
76 [GO] 2021―Sep―24 A hitchhiker's guide through the COVID-19 galaxy Susanna Felsenstein, Andreas Otto Reiff
77 [GO] 2021―Sep―24 Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors - A nationwide survey Shirley Shapiro Ben David, Na’ama Shamir-Stein, Sharon Baruch Gez, Uri Lerner, Daniella Rahamim-Cohen, Anat Ekka Zohar
78 [GO] 2021―Sep―22 A distinct association of inflammatory molecules with outcomes of COVID-19 in younger versus older adults Junghee J. Shin, Sangchoon Jeon, Serhan Unlu, Jennefer Par-Young, Min Sun Shin, John K. Kuster, Yuliya Afinogenova, Yumi Kang, Michael Simonov, Gregory Buller, Richard Bucala, Insoo Kang
79 [GO] 2021―Sep―11 Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China Shengwei Jin, Hui An, Tong Zhou, Ting Li, Chengshui Chen, Binyu Ying, Zhangye Xu, Xiaokun Li, Ming Li
80 [GO] 2021―Sep―08 Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue Waleed H. Mahallawi, Talal M. Aljeraisi
81 [GO] 2021―Aug―31 Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year Giuseppe A. Ramirez, Lorenza M. Argolini, Chiara Bellocchi, Luca Moroni, Emanuel Della-Torre, Nicola Farina, Roberto F. Caporali, Lorenzo Beretta, Maria Gerosa, Enrica P. Bozzolo, Lorenzo Dagna
82 [GO] 2021―Aug―27 Immunomodulation and immunotherapeutics of COVID-19 Sourbh Suren Garg, Atulika Sharma, Jeena Gupta
83 [GO] 2021―Aug―21 Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients Kavita Mathi, Yael Rosenberg-Hasson, Holden Maecker, Dennis J. Carlo, Ronald B. Moss
84 [GO] 2021―Aug―13 Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility Yashini Govender, Sharon Shalekoff, Osman Ebrahim, Ziyaad Waja, Richard E. Chaisson, Neil Martinson, Caroline T. Tiemessen
85 [GO] 2021―Aug―12 COVID-19 in children and young adults with moderate/severe inborn errors of immunity in a high burden area in pre-vaccine era A. Deya-Martinez, A. García-García, E.A. Gonzalez-Navarro, L. Yiyi, A. Vlagea, I. Jordan, V. Fumadó, C. Fortuny, M. Español, C. Launes, A. Esteve-Solé, M. Juan, M. Pascal, L. Alsina
86 [GO] 2021―Aug―04 Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine Miguel García-Grimshaw, Anaclara Michel-Chávez, Juan Mauricio Vera-Zertuche, Javier Andrés Galnares-Olalde, Laura E. Hernández-Vanegas, Melissa Figueroa-Cucurachi, Orlando Paredes-Ceballos, Gustavo Reyes-Terán, Guillermo Carbajal-Sandoval, Santa Elizabeth Ceballos-Liceaga, Antonio Arauz, Sergio Iván Valdés-Ferrer
87 [GO] 2021―Aug―02 BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A systematic review Michael Stack, Keith Sacco, Riccardo Castagnoli, Alicia A. Livinski, Luigi D. Notarangelo, Michail S. Lionakis
88 [GO] 2021―Jul―31 Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection Puya Dehgani-Mobaraki, Asiya Kamber Zaidi, Nidhi Yadav, Alessandro Floridi, Emanuela Floridi
89 [GO] 2021―Jul―23 Understanding the immunological aspects of SARS-CoV-2 causing COVID-19 pandemic: A therapeutic approach Ananya Das, Sraddhya Roy, Snehasikta Swarnakar, Nabanita Chatterjee
90 [GO] 2021―Jul―21 COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City Kaoru Harada, Hsi-en Ho, Charlotte Cunningham-Rundles
91 [GO] 2021―Jul―10 Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19 Simin Jamaly, Maria G. Tsokos, Rhea Bhargava, Olga R. Brook, Jonathan L. Hecht, Reza Abdi, Vaishali R. Moulton, Abhigyan Satyam, George C. Tsokos
92 [GO] 2021―Jun―29 Detection of immunoglobulin response to COVID-19 vaccination using a novel rapid fingerstick assay Beth L. Cobb, Amr H. Sawalha
93 [GO] 2021―Jun―29 Severe COVID-19 pneumonia in Good syndrome with a favorable outcome Maria Lourdes Cos Esquius, Inmaculada López Montesinos, Ramón Gimeno Martinez, Jorge Eguía Núñez, M. Araceli Caballero-Rabasco, Blanca Sánchez González, Alicia López García, Leonardo Mellibovsky
94 [GO] 2021―Jun―18 Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Laura E. Hernández-Vanegas, Isaac Núñez, Noé Hernández-Valdivia, Daniel Amado Carrillo-García, Anaclara Michel-Chávez, Javier Andrés Galnares-Olalde, Guillermo Carbajal-Sandoval, María del Mar Saniger-Alba, Roger A. Carrillo-Mezo, Sergio Fragoso-Saavedra, Alba Espino-Ojeda, Carlos Blaisdell-Vidal, Juan Luis Mosqueda-Gómez, Juan Sierra-Madero, Rogelio Pérez-Padilla, José Luis Alomía-Zegarra, Hugo López-Gatell, José Luis Díaz-Ortega, Gustavo Reyes-Terán, Antonio Arauz, Sergio Iván Valdés-Ferrer
95 [GO] 2021―Jun―09 Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults Kirsi Tamminen, Marjo Salminen, Vesna Blazevic
96 [GO] 2021―Jun―02 Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus Panagiotis A. Ntouros, Nikolaos I. Vlachogiannis, Maria Pappa, Adrianos Nezos, Clio P. Mavragani, Maria G. Tektonidou, Vassilis L. Souliotis, Petros P. Sfikakis
97 [GO] 2021―Apr―28 IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report Raffaele Badolato, Marco Cattalini, Rosaria Scaduto, Sara Roversi, Jessica Galli, Rosalba Monica Ferraro, Manuela Cortesi, Simona Orcesi, Silvia Giliani, Elisa Fazzi
98 [GO] 2021―Apr―28 Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation Viktorija Erdeljic Turk
99 [GO] 2021―Apr―22 SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts Christopher Thor Freda, Wei Yin, Berhane Ghebrehiwet, David A. Rubenstein
100 [GO] 2021―Apr―19 A novel application of delayed-type hipersensitivity reaction to measure cellular immune response in SARS-CoV-2 exposed individuals Yvelise Barrios, Andres Franco, Inmaculada Sanchez-Machin, Paloma Poza-Guedes, Ruperto Gonzalez-Perez, Victor Matheu
101 [GO] 2021―Apr―15 Genetic justification of severe COVID-19 using a rigorous algorithm Eleni Gavriilaki, Panagiotis G. Asteris, Tasoula Touloumenidou, Evaggelia-Evdoxia Koravou, Maria Koutra, Penelope Georgia Papayanni, Vassiliki Karali, Apostolia Papalexandri, Christos Varelas, Fani Chatzopoulou, Maria Chatzidimitriou, Dimitrios Chatzidimitriou, Anastasia Veleni, Savvas Grigoriadis, Evdoxia Rapti, Diamantis Chloros, Ioannis Kioumis, Evaggelos Kaimakamis, Milly Bitzani, Dimitrios Boumpas, Argyris Tsantes, Damianos Sotiropoulos, Ioanna Sakellari, Ioannis G. Kalantzis, Stefanos T. Parastatidis, Mohammadreza Koopialipoor, Liborio Cavaleri, Danial J. Armaghani, Anastasia Papadopoulou, Robert Alan Brodsky, Styliani Kokoris, Achilles Anagnostopoulos
102 [GO] 2021―Apr―09 The microbiota-mediated dietary and nutritional interventions for COVID-19 Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Massimiliano Peana, Alain Menzel, Maryam Dadar, Asma Gasmi Benahmed, Geir Bjørklund
103 [GO] 2021―Apr―07 Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products Ariel Kenig, Yuval Ishay, Fadi Kharouf, Limor Rubin
104 [GO] 2021―Apr―03 Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon Karolina Akinosoglou, Ilektra Tzivaki, Markos Marangos
105 [GO] 2021―Apr―02 Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients Francesco Perna, Sara Bruzzaniti, Erica Piemonte, Valeria Maddaloni, Lidia Atripaldi, Silvia Sale, Alessandro Sanduzzi, Carmine Nicastro, Nicola Pepe, Maurizio Bifulco, Giuseppe Matarese, Mario Galgani, Luigi Atripaldi
106 [GO] 2021―Mar―24 Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19 Abhigyan Satyam, Maria G. Tsokos, Olga R. Brook, Jonathan L. Hecht, Vaishali R. Moulton, George C. Tsokos
107 [GO] 2021―Mar―07 Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study Meruyert Dauletova, Hafsan Hafsan, Negah Mahhengam, Angelina Olegovna Zekiy, Majid Ahmadi, Homayoon Siahmansouri
108 [GO] 2021―Feb―25 The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection Nikolaos I. Vlachogiannis, Kleio-Maria Verrou, Konstantinos Stellos, Petros P. Sfikakis, Dimitrios Paraskevis
109 [GO] 2021―Feb―21 Coronavirus-induced autoimmunity Valéry Salle
110 [GO] 2021―Feb―16 Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort Francesca Caccuri, Antonella Bugatti, Antonella Meini, Carlo Bonfanti, Mario Motta, Lucia Savarè, Alberto Arrighini, Maria Pia Bondioni, Vassilios Lougaris, Arnaldo Caruso, Alessandro Plebani
111 [GO] 2021―Feb―05 Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients Isaac Núñez, Ángel A. Priego-Ranero, H. Benjamín García-González, Brenda Jiménez-Franco, Rebeca Bonilla-Hernández, Guillermo Domínguez-Cherit, Javier Merayo-Chalico, José C. Crispín, Ana Barrera-Vargas, Sergio Iván Valdés-Ferrer
112 [GO] 2021―Jan―12 Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” Rossella Talotta
113 [GO] 2021―Jan―09 SARS-CoV-2 infection associated with hepatitis in an infant with X-linked severe combined immunodeficiency Nicolai S.C. van Oers, Natasha W. Hanners, Paul Sue, Victor Aquino, Quan-Zhen Li, John W. Schoggins, Christian A. Wysocki
114 [GO] 2020―Dec―16 Interrelations between COVID-19 and other disorders Amin Gasmi, Massimiliano Peana, Lyudmila Pivina, Shvetha Srinath, Asma Gasmi Benahmed, Yuliya Semenova, Alain Menzel, Maryam Dadar, Geir Bjørklund
115 [GO] 2020―Dec―16 Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned Varvara A. Ryabkova, Leonid P. Churilov, Yehuda Shoenfeld
116 [GO] 2020―Dec―08 Fatal SARS-CoV-2 infection in a male patient with Good's syndrome Maria Rosa Pozzi, Manuela Baronio, Maria Bianchi Janetti, Luisa Gazzurelli, Daniele Moratto, Marco Chiarini, Alessandro Plebani, Vassilios Lougaris
117 [GO] 2020―Dec―07 Kawasaki or Kawasaki-like disease? A debate on COVID-19 infection in children Mohammad-Salar Hosseini
118 [GO] 2020―Nov―28 Peripheral immunological features of COVID-19 patients in Taizhou, China: A retrospective study Xiao-Hong Jin, Hui-Li Zhou, Ling-Ling Chen, Guan-Fu Wang, Qiu-Yue Han, Jian-Gang Zhang, Xia Zhang, Qiong-Yuan Chen, Yao-Han Ye, Aifen Lin, Wei-Hua Yan
119 [GO] 2020―Nov―17 COVID-19: A review of therapeutic strategies and vaccine candidates Vladislav Izda, Matlock A. Jeffries, Amr H. Sawalha
120 [GO] 2020―Nov―13 Major reduction of NKT cells in patients with severe COVID-19 pneumonia Maria Antonella Zingaropoli, Valentina Perri, Patrizia Pasculli, Francesco Cogliati Dezza, Parni Nijhawan, Giulia Savelloni, Giuseppe La Torre, Claudia D'Agostino, Fabio Mengoni, Miriam Lichtner, Maria Rosa Ciardi, Claudio Maria Mastroianni
121 [GO] 2020―Nov―12 Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort Hèctor Corominas, Ivan Castellví, Virginia Pomar, Rosa Antonijoan, Isabel Mur, Laia Matas, Ignasi Gich, Natividad de Benito, Ana Laiz, Diego Castillo, Laura Villamarin, David Filella, Ana Milena Millán, María Ángeles Quijada, Mireia Puig, Jordi Casademont, Pere Domingo
122 [GO] 2020―Oct―27 Commentary on “Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy” by D.C. Mastellos et al. Isabel Kinney Ferreira de Miranda Santos, Cristina Ribeiro de Barros Cardoso
123 [GO] 2020―Oct―25 Response to “Comment on Mastellos and colleagues and efficacy of complement-targeting drugs in COVID-19 Dimitrios C. Mastellos, John D. Lambris
124 [GO] 2020―Oct―23 Laboratory biomarkers associated with COVID-19 severity and management S. Keddie, O. Ziff, M.K.L. Chou, R.L. Taylor, A. Heslegrave, E. Garr, N. Lakdawala, A. Church, D. Ludwig, J. Manson, M. Scully, E. Nastouli, M.D. Chapman, M. Hart, M.P. Lunn
125 [GO] 2020―Oct―23 An enlightening role for cytokine storm in coronavirus infection Zhongyi Zhao, Yinhao Wei, Chuanmin Tao
126 [GO] 2020―Oct―14 Proinflammatory cytokines are associated with prolonged viral RNA shedding in COVID-19 patients Chun Gao, Li Zhu, Cheng Cheng Jin, Yi Xin Tong, Ai Tang Xiao, Sheng Zhang
127 [GO] 2020―Sep―19 Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy Dimitrios C. Mastellos, Bruno G.P. Pires da Silva, Benedito A.L. Fonseca, Natasha P. Fonseca, Maria Auxiliadora-Martins, Sara Mastaglio, Annalisa Ruggeri, Marina Sironi, Peter Radermacher, Akrivi Chrysanthopoulou, Panagiotis Skendros, Konstantinos Ritis, Ilenia Manfra, Simona Iacobelli, Markus Huber-Lang, Bo Nilsson, Despina Yancopoulou, E. Sander Connolly, Cecilia Garlanda, Fabio Ciceri, Antonio M. Risitano, Rodrigo T. Calado, John D. Lambris
128 [GO] 2020―Sep―10 On the genetics and immunopathogenesis of COVID-19 Chaim Oscar Jacob
129 [GO] 2020―Sep―06 SARS-CoV-2 infections in children and young people Susanna Felsenstein, Christian M. Hedrich
130 [GO] 2020―Aug―29 Interferon gamma, TGF-β1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients María Caridad Montalvo Villalba, Odalys Valdés Ramirez, Mayra Muné Jiménez, Amely Arencibia Garcia, Javier Martinez Alfonso, Guelsy González Baez, Rosmery Roque Arrieta, Dianelvys Rosell Simón, Delmis Alvárez Gainza, Beatriz Sierra Vazquez, Sonia Resik Aguirre, Maria Guadalupe Guzmán Tirado
131 [GO] 2020―Aug―15 Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients Ignacio Iturrieta-Zuazo, Claudia Geraldine Rita, Ana García-Soidán, Ana de Malet Pintos-Fonseca, Nieves Alonso Alarcón, Roberto Pariente Rodríguez, Amalia Tejeda Velarde, Sergio Serrano Villar, José Luis Castañer Alabau, Israel Nieto Gañán
132 [GO] 2020―Aug―06 Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19 Jeffrey Laurence, J. Justin Mulvey, Madhav Seshadri, Alexandra Racanelli, Joanna Harp, Edward J. Schenck, Dana Zappetti, Evelyn M. Horn, Cynthia M. Magro
133 [GO] 2020―Jul―31 Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy G.P. Chrousos, G.U. Meduri
134 [GO] 2020―Jul―23 Micronutrients as immunomodulatory tools for COVID-19 management Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Massimiliano Peana, Alain Menzel, Maryam Dadar, Asma Gasmi Benahmed, Geir Bjørklund
135 [GO] 2020―Jul―22 Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine Homam Ibrahim, Andras Perl, Deane Smith, Tyler Lewis, Zachary Kon, Ronald Goldenberg, Kinan Yarta, Cezar Staniloae, Mathew Williams
136 [GO] 2020―Jul―13 mTORC inhibitor Sirolimus deprograms monocytes in “cytokine storm” in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome Claudio Karsulovic, Mercedes Lopez, Fabian Tempio, Julia Guerrero, Annelise Goecke
137 [GO] 2020―Jul―12 Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation? James R. McIlroy, Benjamin H. Mullish, Simon D. Goldenberg, Gianluca Ianiro, Julian R. Marchesi
138 [GO] 2020―Jul―11 Long-term infection of SARS-CoV-2 changed the body's immune status Lan Lin, Shanshan Luo, Renjie Qin, Mengling Yang, Xiaobei Wang, Qianqian Yang, Yang Zhang, Quansheng Wang, Rui Zhu, Heng Fan, Haijun Wang, Yu Hu, Lin Wang, Desheng Hu
139 [GO] 2020―Jun―27 Imatinib for COVID-19: A case report Alejandro Morales-Ortega, David Bernal-Bello, Cristina Llarena-Barroso, Begoña Frutos-Pérez, Miguel Ángel Duarte-Millán, Vanessa García de Viedma-García, Ana Isabel Farfán-Sedano, Eduardo Canalejo-Castrillero, José Manuel Ruiz-Giardin, Justo Ruiz-Ruiz, Juan Víctor San Martín-López
140 [GO] 2020―Jun―23 Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment Swamy Yeleswaram, Paul Smith, Timothy Burn, Maryanne Covington, Ashish Juvekar, Yanlong Li, Peg Squier, Peter Langmuir
141 [GO] 2020―Jun―20 COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential Yujie Jiang, Xin Wei, Jingjing Guan, Shuang Qin, Zhongyong Wang, Hong Lu, Jingjing Qian, Lianfeng Wu, Yingxiao Chen, Yanfan Chen, Xiangyang Lin
142 [GO] 2020―Jun―13 Development of child immunity in the context of COVID-19 pandemic Małgorzata Kloc, Rafik M. Ghobrial, Ernest Kuchar, Sławomir Lewicki, Jacek Z. Kubiak
143 [GO] 2020―Jun―12 Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy Ciceri Fabio, Castagna Antonella, Rovere-Querini Patrizia, De Cobelli Francesco, Ruggeri Annalisa, Galli Laura, Conte Caterina, De Lorenzo Rebecca, Poli Andrea, Ambrosio Alberto, Signorelli Carlo, Bossi Eleonora, Fazio Maria, Tresoldi Cristina, Colombo Sergio, Monti Giacomo, Fominskiy Efgeny, Franchini Stefano, Spessot Marzia, Martinenghi Carlo, Carlucci Michele, Beretta Luigi, Scandroglio Anna Maria, Clementi Massimo, Locatelli Massimo, Tresoldi Moreno, Scarpellini Paolo, Martino Gianvito, Bosi Emanuele, Dagna Lorenzo, Lazzarin Adriano, Landoni Giovanni, Zangrillo Alberto
144 [GO] 2020―Jun―09 Antibody-dependent enhancement and COVID-19: Moving toward acquittal Eric J. Yager
145 [GO] 2020―Jun―08 A plea for the pathogenic role of immune complexes in severe Covid-19 Dominique A. Vuitton, Lucine Vuitton, Estelle Seillès, Pierre Galanaud
146 [GO] 2020―May―31 Treating COVID-19 with colchicine in community healthcare setting Emanuel Della-Torre, Fabrizio Della-Torre, Marija Kusanovic PCP, Raffaella Scotti, Giuseppe Alvise-Ramirez, Lorenzo Dagna, Moreno Tresoldi
147 [GO] 2020―May―29 Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients J.M. Urra, C.M. Cabrera, L. Porras, I. Ródenas
148 [GO] 2020―May―29 Type 3 hypersensitivity in COVID-19 vasculitis Luca Roncati, Giulia Ligabue, Luca Fabbiani, Claudia Malagoli, Graziana Gallo, Beatrice Lusenti, Vincenzo Nasillo, Antonio Manenti, Antonio Maiorana
149 [GO] 2020―May―28 Racial disparity in Covid-19 mortality rates - A plausible explanation Yuval Tal, Avner Adini, Alal Eran, Irit Adini
150 [GO] 2020―May―24 Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases Aristo Vojdani, Datis Kharrazianb
151 [GO] 2020―May―21 Can Ticagrelor be used to prevent sepsis-induced coagulopathy in COVID-19? Loukman Omarjee, Olivier Meilhac, Frédérique Perrot, Anne Janin, Guillaume Mahe
152 [GO] 2020―May―15 Supplements for COVID-19: A modifiable environmental risk Trevor K. Young, John G. Zampella
153 [GO] 2020―May―13 Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19 Loukman Omarjee, Anne Janin, Frédérique Perrot, Bruno Laviolle, Olivier Meilhac, Guillaume Mahe
154 [GO] 2020―May―11 Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution! Alan A. Nguyen, Saddiq B. Habiballah, Craig D. Platt, Raif S. Geha, Janet S. Chou, Douglas R. McDonald
155 [GO] 2020―Apr―29 The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 Sara Mastaglio, Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos, Markus Huber-Lang, Simona Piemontese, Andrea Assanelli, Cecilia Garlanda, John D. Lambris, Fabio Ciceri
156 [GO] 2020―Apr―27 COVID-19: Immunology and treatment options Susanna Felsenstein, Jenny A. Herbert, Paul S. McNamara, Christian M. Hedrich
157 [GO] 2020―Apr―24 A strategy targeting monocyte-macrophage differentiation to avoid pulmonary complications in SARS-Cov2 infection J. Gómez-Rial
158 [GO] 2020―Apr―20 COVID-19 pathophysiology: A review Koichi Yuki, Miho Fujiogi, Sophia Koutsogiannaki
159 [GO] 2020―Apr―18 On the molecular determinants the SARS-CoV-2 attack Darja Kanduc, Yehuda Shoenfeld
160 [GO] 2020―Apr―10 COVID-19 - Considerations for the paediatric rheumatologist Christian M. Hedrich
161 [GO] 2020―Apr―08 COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster Yuanyuan Han, Mao Jiang, Da Xia, Lichao He, Xin Lv, Xiaohua Liao, Jie Meng
162 [GO] 2020―Apr―08 Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients Amr H. Sawalha, Ming Zhao, Patrick Coit, Qianjin Lu
163 [GO] 2020―Apr―07 Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic Amin Gasmi, Sadaf Noor, Torsak Tippairote, Maryam Dadar, Alain Menzel, Geir Bjørklund
164 [GO] 2020―Apr―01 Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19 Jie Ma, Peng Xia, Yangzhong Zhou, Zhengyin Liu, Xiang Zhou, Jinglan Wang, Taisheng Li, Xiaowei Yan, Limeng Chen, Shuyang Zhang, Yan Qin, Xuemei Li
165 [GO] 2020―Mar―25 The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China Wen Zhang, Yan Zhao, Fengchun Zhang, Qian Wang, Taisheng Li, Zhengyin Liu, Jinglan Wang, Yan Qin, Xuan Zhang, Xiaowei Yan, Xiaofeng Zeng, Shuyang Zhang
 [1] 

165 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec